Cipla
Pratik Dahiwale is a seasoned professional in the pharmaceutical industry with extensive experience in strategic management and product marketing. Currently serving as Senior Manager in Commercial for Emerging Markets at Cipla since July 2024, Pratik has previously held significant roles including Senior Manager and Executive Assistant to the Executive Director at Akums Drugs & Pharmaceuticals Ltd, where responsibilities encompassed strategic initiatives for high growth across multiple manufacturing plants. Prior positions include Manager and Executive Assistant to the President of Glenmark Pharmaceuticals, where Pratik contributed to corporate strategy and market analysis, Assistant Manager to the Chairman at Cadila Pharmaceuticals, and other roles focused on product management and sales growth. Pratik holds a Post Graduate Programme in Management from the Indian Institute of Management Amritsar and a Bachelor of Engineering in Computer Engineering from the University of Mumbai.
This person is not in the org chart
Cipla
18 followers
Cipla is a pharmaceutical company. The Company's strategic business units include Active Pharmaceutical Ingredients (APIs), Respiratory and Cipla Global Access. The Company's geographical segments include India, USA, South Africa and Rest of the World. The Company manufactures metered dose inhalers, dry powder inhalers, nasal sprays, nebulizers and a range of inhaled accessory devices. Cipla Global Access is a tender-based institutional business that concentrates on approximately four therapy areas: human immunodeficiency virus/acquired immuno deficiency syndrome (HIV/AIDS), malaria, multi drug-resistant tuberculosis and reproductive health. The Company offers its products for the therapeutic areas, including cardiovascular, children's health, dermatology and cosmetology, diabetes, HIV/AIDS, infectious diseases and critical care, malaria, neurosciences, oncology, ophthalmology, osteoporosis, respiratory, urology and women's health.